NURESCA Trademark Information

Trademark by Pfizer Inc.

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabe...

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: NURESCA
Status/Status Date:
ABANDONED - NO STATEMENT OF USE FILED
7/9/2018
Serial Number: 86442426
Filing Date: 11/3/2014
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 4/7/2015
Last Applicant/Owner:
Pfizer Inc.
New York, NY 10017
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
PFIZER INC.
235 E 42ND ST
NEW YORK, NY 10017-5703
Current Status:
ABANDONED - NO STATEMENT OF USE FILED
7/9/2018
Correspondent Search:
RICHARD A. FRIEDMAN is a correspondent of NURESCA trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on